Hyderabad Telangana, India

Rapolu Raji Reddy

USPTO Granted Patents = 50 


 

Average Co-Inventor Count = 4.9

ph-index = 4

Forward Citations = 53(Granted Patents)

Forward Citations (Not Self Cited) = 50(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Hyderabad, IN (2006 - 2015)
  • Andhrapradesh, IN (2009 - 2017)
  • Andrah Pradesh, IN (2017)

Company Filing History:


Years Active: 2006-2017

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Amorphous Darunavir
Polymorphs of Darunavir
Crystalline Hydrochloride Salt
Resolution of Omeprazole
Salts of Raltegravir
Polymorphs of Erlotinib
Optical Resolution of Benzimidazoles
Stereoselective Synthesis of Sulfoxides
Polymorphs of Efavirenz
Process for Oseltamivir Phosphate
Crystalline Particles of Eprosartan
Polymorphs of Sunitinib Malate
50 patents (USPTO):Explore Patents

Title: Rapolu Raji Reddy: Pioneering Innovations in Pharmaceuticals

Introduction:

In the realm of pharmaceutical innovations, Rapolu Raji Reddy has emerged as a leading inventor with an impressive portfolio of patents. Hailing from Hyderabad, India, Reddy has made significant contributions to the field through his groundbreaking research and development work. With 51 patents to his name, he has truly established himself as a distinguished figure in the pharmaceutical industry.

Patents and Inventions by Rapolu Raji Reddy:

Two of Reddy's latest patents stand out as noteworthy examples of his innovative contributions. The first patent describes the creation of pure amorphous darunavir - an important pharmaceutical compound. Reddy's research encompasses the methods of producing pure amorphous darunavir, as well as the inclusion of this compound in pharmaceutical compositions using appropriate excipients.

The second patent unveils the discovery of novel solvated forms of darunavir. Reddy's research not only outlines the preparation methods for these solvated forms but also introduces the amorphous form of darunavir and its inclusion in pharmaceutical compositions. The invention of darunavir 2-methyl-2-butanol solvate and the subsequent manufacturing processes highlight Reddy's commitment to advancing pharmaceutical innovations.

Professional Background and Collaborations:

Rapolu Raji Reddy has proven his expertise and dedication through his association with esteemed organizations in the pharmaceutical industry. He has worked with the Hetero Research Foundation and the renowned Hetero Drugs Limited. These companies have played a significant role in developing and manufacturing high-quality generic pharmaceutical products, emphasizing their commitment to scientific excellence and global healthcare accessibility.

Reddy's collaboration with fellow inventors, Bandi Parthasaradhi Reddy and Kura Rathnakar Reddy, showcases a collective commitment towards advancing pharmaceutical research. Through their collaborations, they have combined their expertise to contribute to the development of innovative pharmaceutical solutions.

Conclusion:

Rapolu Raji Reddy's groundbreaking patents and inventions in the pharmaceutical field have positioned him as a leading figure in the industry. His dedication to advancing pharmaceutical research and development has resulted in significant contributions that impact the healthcare landscape. Reddy's work exemplifies the importance of innovative thinking, collaboration, and persistence in driving advancements in the pharmaceutical industry. As he continues to expand his portfolio, his contributions are sure to shape the future of pharmaceutical innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…